| NAME |
INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (EXTAVIA) |
| VA GENERIC NAME |
INTERFERON BETA-1B |
| DOSAGE FORM |
INJ,LYPHL |
| FDA MED GUIDE |
Interferon_Beta-1b_(Extavia)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
0.3 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| UNITS |
MG/VIAL |
| NATIONAL FORMULARY NAME |
INTERFERON BETA-1B INJ,LYPHL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
INTERFERON BETA-1B 0.3MG/VIL (EXTAVIA) |
| VA PRODUCT IDENTIFIER |
I0504 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
VI |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4029542 |
| EFFECTIVE DATE/TIME |
-
- 2010-01-12 00:00:00
- STATUS: ACTIVE
|
